Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
Keywords: Antiviral agents; Direct-acting antivirals; Polymerase inhibitor; NS5A inhibitor; EC50; half-maximal effective concentration; HCV; hepatitis C virus; LLOQ; lower limit of quantification; RASs; resistance-associated substitutions; SVR; sustained virologica